Literature DB >> 8335986

Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence.

W G Powderly1, K Robinson, E J Keath.   

Abstract

The causative strains in 22 patients with recurrent oral candidiasis were examined using two DNA probes (a Histoplasma capsulatum DNA probe that cross-hybridizes with Candida albicans and a C. albicans strain-specific probe derived from repetitive sequence DNA). C. albicans was the causative organism in all 22 initial episodes of infection and was also obtained from 17 patients with recurrent oral disease. Molecular analysis showed that in 11 cases, the same isolate was identified in each episode. Six patients had a clearly different isolate of C. albicans causing a later episode of candidiasis. Five patients had different Candida species causing recurrent disease: 4, Torulopsis glabrata; 1, Candida parapsilosis. Patients with a new isolate (either new species or a new C. albicans strain) were more immunosuppressed and were significantly more likely (P < .001) than patients with the same recurrent strain to have received suppressive azole antifungal agents. These data indicate that the epidemiology of recurrent candidiasis in individual patients seropositive for the human immunodeficiency virus is complex and that both failure of eradication of Candida from the oral cavity and new infection occur.

Entities:  

Mesh:

Year:  1993        PMID: 8335986     DOI: 10.1093/infdis/168.2.463

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Effects of glycyrrhizin, an active component of licorice roots, on Candida albicans infection in thermally injured mice.

Authors:  T Utsunomiya; M Kobayashi; D N Herndon; R B Pollard; F Suzuki
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Genetic dissimilarity of two fluconazole-resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient.

Authors:  J Berenguer; T M Diaz-Guerra; B Ruiz-Diez; J C Bernaldo de Quiros; J L Rodriguez-Tudela; J V Martinez-Suarez
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

3.  Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model.

Authors:  F Barchiesi; L K Najvar; M F Luther; G Scalise; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.

Authors:  P Boerlin; F Boerlin-Petzold; J Goudet; C Durussel; J L Pagani; J P Chave; J Bille
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

Review 5.  Azole resistance in Candida.

Authors:  D W Denning; G G Baily; S V Hood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

6.  Molecular probe for typing strains of Candida albicans.

Authors:  P Postlethwait; B Bell; W T Oberle; P Sundstrom
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

7.  Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.

Authors:  T F Patterson; S G Revankar; W R Kirkpatrick; O Dib; A W Fothergill; S W Redding; D A Sutton; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  Comparison of four molecular typing methods for evaluating genetic diversity among Candida albicans isolates from human immunodeficiency virus-positive patients with oral candidiasis.

Authors:  T M Díaz-Guerra; J V Martínez-Suárez; F Laguna; J L Rodríguez-Tudela
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

Review 9.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole.

Authors:  D Garcia-Hermoso; F Dromer; L Improvisi; F Provost; B Dupont
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.